Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), a specialty pharmaceutical company, is committed to providing prescription drugs designed to address central nervous system (CNS) disorders. Currently, the company is building a core portfolio of both marketed and development-stage products that attend to substantial, but unmet medical needs. Questcor’s aim is to develop and commercialize their own proprietary products, while staying open to partnering concepts to leverage assets and further build its portfolio. For further information, visit the Company’s web site at www.questcor.com.
- 16 years ago
QualityStocks
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR)
Tags Rodman & Renshaw
Related Post
-
D-Wave Quantum Inc. (NYSE: QBTS) Expands Quantum Optimization Offerings to Accelerate Commercial Adoption
At its Qubits 2025 user conference, D-Wave introduced new hybrid solver capabilities supporting continuous variables…
-
Soligenix Inc. (NASDAQ: SNGX) Advances CiVax Amid Ongoing COVID-19 Threat
An increase in deaths from COVID-19 underscores the persistent danger of the virus and the…
-
Thumzup Media Corp. (NASDAQ: TZUP) Continues Building Its Client Base with Its Proprietary Tech for Ad Campaigns
Social media commerce is expected to grow to $821 billion in 2025[1], demonstrating its importance…